{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:16:41Z","timestamp":1784557001775,"version":"3.55.0"},"reference-count":11,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,4]]},"abstract":"Summary<\/jats:title>\n \n We describe the case of a young Hispanic female who presented with thyrotoxicosis with seizures and ischemic stroke. She was diagnosed with a rare vasculopathy \u2013 moyamoya syndrome. After starting antithyroid therapy, her neurologic symptoms did not improve. Acute neurosurgical intervention had relieved her symptoms in the immediate post-operative period after re-anastomosis surgery. However, 2 post-operative days later, she was found to be in status epilepticus and in hyperthyroid state. She quickly deteriorated clinically and had expired a few days afterward. This is the second case in literature of a fatality in a patient with moyamoya syndrome and Graves\u2019 disease. However, unlike the other case report, our patient had undergone\n successful<\/jats:italic>\n revascularization surgery. We believe her underlying non-euthyroid state had potentiated her clinical deterioration. Case studies have shown positive correlation between uncontrolled hyperthyroidism and stroke-like symptoms in moyamoya syndrome. Mostly all patients with these two disease processes become symptomatic in marked hyperthyroid states. Thus, it may be either fluctuations in baseline thyroid function or thyrotoxicosis that potentiate otherwise asymptomatic moyamoya vasculopathy.\n <\/jats:p>\n \n Learning points:<\/jats:title>\n \n \n Awareness of the association between Graves\u2019 disease and moyamoya syndrome in younger patients presenting with stroke-like symptoms.<\/jats:p>\n <\/jats:list-item>\n \n Obtaining euthyroid states before undergoing revascularization surgery may protect the patient from perioperative mortality and morbidity.<\/jats:p>\n <\/jats:list-item>\n \n Although moyamoya disease is usually thought to be genetically associated, there are reports that thyroid antibodies may play a role in its pathogenesis and have an autoimmune link.<\/jats:p>\n <\/jats:list-item>\n \n Fluctuations in baseline thyroid function for patients with known Graves\u2019 disease may be a potentiating factor in exacerbating moyamoya vasculopathy.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>","DOI":"10.1530\/edm-16-0045","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T05:31:42Z","timestamp":1478237502000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":3,"title":["Fatal outcome in a Hispanic woman with moyamoya syndrome and Graves\u2019 disease"],"prefix":"10.1530","volume":"2016","author":[{"given":"Julian","family":"Choi","sequence":"first","affiliation":[{"name":"1Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perin","family":"Suthakar","sequence":"additional","affiliation":[{"name":"2Neurology, Arrowhead Regional Medical Center, Colton, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Farmand","sequence":"additional","affiliation":[{"name":"1Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"key20161114125722546_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3171\/2014.10.JNS141140","article-title":"Clinical features and disease progression in moyamoya disease patients with Graves disease","volume":"123","author":"Chen","year":"2015","journal-title":"Journal of Neurosurgery"},{"key":"key20161114125722546_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.wneu.2016.04.122","article-title":"Acute thyrotoxicosis of Graves disease associated with moyamoya vasculopathy and stroke in Latin American women: a case series and review of the literature","volume":"92","author":"Shah","year":"2016","journal-title":"World Neurosurgery"},{"key":"key20161114125722546_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","article-title":"Association of thyroid autoantibodies with Moyamoya-type cerebrovascular disease: a prospective study","volume":"41","author":"Kim","year":"2009","journal-title":"Stroke"},{"key":"key20161114125722546_bib4","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.clineuro.2013.02.018","article-title":"Coexistence of moyamoya and Graves\u2019 diseases: the clinical characteristics and treatment effects of 21 Chinese patients","volume":"115","author":"Li","year":"2009","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"key20161114125722546_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2176\/nmc.50.977","article-title":"Efficacy of revascularization surgery for moyamoya syndrome associated with Graves\u2019 disease","volume":"50","author":"Endo","year":"2010","journal-title":"Neurologia Medico-Chirurgica"},{"key":"key20161114125722546_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10143-011-0311-z","article-title":"Concurrent Graves\u2019 disease and intracranial arterial stenosis\/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment","volume":"34","author":"Ohba","year":"2011","journal-title":"Neurosurgical Review"},{"key":"key20161114125722546_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/thy.1997.7.625","article-title":"Concurrence of Graves\u2019 disease and dysplastic cerebral blood vessels of the moyamoya variety","volume":"7","author":"Tendler","year":"1997","journal-title":"Thyroid"},{"key":"key20161114125722546_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4158\/EP.9.4.290","article-title":"Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events","volume":"9","author":"Colleran","year":"2003","journal-title":"Endocrine Practice"},{"key":"key20161114125722546_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3349\/ymj.2009.50.4.594","article-title":"A case of Moyamoya disease in a girl with thyrotoxicosis","volume":"50","author":"Lee","year":"2009","journal-title":"Yonsei Medical Journal"},{"key":"key20161114125722546_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3171\/jns.2005.102.6.1013","article-title":"Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management","volume":"102","author":"Im","year":"2005","journal-title":"Journal of Neurosurgery"},{"key":"key20161114125722546_bib11","first-page":"643","article-title":"Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis","volume":"27","author":"Hsu","year":"2006","journal-title":"American Journal of Neuroradiology"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2016\/1\/EDM16-0045.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2016\/1\/EDM16-0045.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:46:19Z","timestamp":1784555179000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.1530\/edm-16-0045","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]}}}